From far away you see more
Von weit weg sieht man mehr (from far away you see more) is the title of an exhibition at the Kunsthaus Graz, an iconic modern art museum known as the “Friendly Alien” for its cutting edge design akin to a space ship which has landed in the city.
The same concept could also apply to cell therapy, as well as oncology new product development in general.
It’s all too easy to get bogged down in the weeds and overwhelmed by detail – sometimes you need to step back to look from the distance to see more clearly and, in particular, the innovation or evolution currently happening in the field.
Some developments might look relatively small or even curious in nature, yet can turn out to be surprisingly ahead of their time, while others may portend issues ahead for the wise.
In this latest post, we take a look at a variety of novel CAR-T cell therapies involving some more unusual targets or designs and discuss some of the challenges and opportunities they face.
To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.
This content is restricted to subscribers